NCT02101580View on ClinicalTrials.gov

Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

November 17, 2014

Primary Completion Date

May 5, 2017

Study Completion Date

October 6, 2017

Conditions

Advanced Pancreatic Cancer

Interventions

DRUG

ADI-PEG 20

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Polaris Group

INDUSTRY